A pharmaceutical suspension is synthesized such that a significant amount of salt is formed during neutralization. This micro-fine suspension is washed out of salt by diafiltration and further concentrated. Initial salt concentration is about 10% and the active ingredient is around 3.5%. The desired final concentration is almost no salt (< 0.1%) and 7.5% active ingredient.

The fineness of the suspension requires microfiltration. With conventional crossflow technology a further concentration of the suspension is impossible due to the high viscosity. Therefore, dynamic crossflow filtration is required. Systems with rotating ceramic discs have too low throughput and require 100 m² filter area. Hence the BoCross Dynamic Filter is the only available technology for this challenging separation task.

Three 8 m² BoCross Dynamic Filters are applied for thickening and washing of this viscous suspension achieving the target values of 7.8% active ingredient and 0.1% salt.

BoCross Dynamic Filter L8 – Hygenic Design

Units installed

[ - ]

3

Filter area per unit

[m²]

8

Material

[ - ]

1.4435 (316 L)

Filter drive power

[kW]

20

Foot print per unit

[m²]

2

Year of commissioning

[ - ]

2 units in 2008 / 1 unit in 2016

 

Process and Operation Data

Solids content in feed

[wt -%]

3

Solids content in retentate

[wt -%]

7.8

Solids content in filtrate

[g/l]

Free of particles

Washing out of salt

[ - ]

1 : 100

Operation pressure

[bar, g]

1.5 – 3.0

 

Product Data

Product   Iron hydroxide (pharmaceutical product)
Range of particle sizes [µm] 1 – 50
Flow behaviour ­ thixotropic

 

Any Questions? One Call is enough.

© 2022 BOKELA GmbH Karlsruhe, Germany

You still have something on the Watchlist